Drug Profile
DTwP rHepB Hib IPV vaccine- GSK/Biological E.
Alternative Names: DTwP-HBV-HIB-IPVLatest Information Update: 02 Jul 2023
Price :
$50
*
At a glance
- Originator Biological E Limited; GlaxoSmithKline
- Developer Biological E Limited; GSK
- Class Bacterial vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Poliomyelitis; Tetanus
Most Recent Events
- 28 Feb 2022 No recent reports of development identified for phase-I development in Diphtheria(In infants, Prevention) in India (IM, Injection)
- 28 Feb 2022 No recent reports of development identified for phase-I development in Haemophilus-infections(In infants, Prevention) in India (IM, Injection)
- 28 Feb 2022 No recent reports of development identified for phase-I development in Hepatitis-B(In infants, Prevention) in India (IM, Injection)